Woman with stage-3 colorectal cancer recovers in four months using new immunotherapy Patient Mrinali Dhembla has Lynch syndrome, making tumors vulnerable to immunotherapy Dual drug regimen nivolumab and ipilimumab approved by FDA in 2024 was used